Enhanced oxidative phosphorylation correlates with adverse prognostic markers, including ZAP-70 expression and unmutated IGHV status, which is driven by BCR and PI3K signaling in CLL patients29. The gene discussed is PIK3CA; the disease is B-cell chronic lymphocytic leukemia.